ARTICLE | Clinical News
EVT 103: Phase I data
March 15, 2010 7:00 AM UTC
In a double-blind, placebo-controlled, single- and multiple-ascending dose Phase I trial in 72 healthy male volunteers, oral EVT 103 was well tolerated with only a minimal effect of food on the pharma...